Clinical trial
Growth Hormone, Cardiovascular Risk, and Visceral Adiposity
NCT00131378 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Growth Hormone, Cardiovascular Risk, and Visceral Adiposity
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- June 30, 2013
- Enrollment
- 142 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.